학술논문
Phase 1b study of cobimetinib plus atezolizumab in patients with advanced BRAFV600 wild-type melanoma progressing on prior anti–programmed death-1 therapy
Document Type
Article
Author
Source
In European Journal of Cancer January 2023 178:180-190
Subject
Language
ISSN
0959-8049